|
Insider Trading: Pharmasset Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmasset Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Pharmasset Inc since year 2005. Table 2 shows the detailed insider transactions of Pharmasset Inc since 2005.
The reporting company's ticker symbol is VRUS.
The reporting company's CIK number is 1301081.
The total value of stock buying since 2005 is $15,078,687.
The total value of stock sales is $28,265,752.
The total value of stock exercises is $1,080,958.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Pharmasset Inc (VRUS) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Pharmasset Inc (VRUS) in the past 24 months. See table 2 for insider transaction details.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Pharmasset Inc (VRUS).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-11 | 0 | 0 | 32,521 | 594,824 | 18,750 | 260,249 |
| 2008-08 | 0 | 0 | 5,835 | 125,412 | 5,835 | 17,505 |
| 2008-06 | 0 | 0 | 1,040,293 | 20,946,717 | 2,976 | 12,499 |
| 2008-05 | 0 | 0 | 102,097 | 1,810,883 | 102,097 | 453,186 |
| 2008-04 | 0 | 0 | 48,907 | 978,977 | 38,400 | 165,022 |
| 2008-03 | 5,000 | 78,720 | 0 | 0 | 0 | 0 |
| 2008-02 | 0 | 0 | 166,523 | 3,808,939 | 26,666 | 79,998 |
| 2007-09 | 0 | 0 | 0 | 0 | 10,000 | 30,000 |
| 2007-08 | 0 | 0 | 0 | 0 | 20,833 | 62,499 |
| 2007-05 | 1,555,552 | 13,999,968 | 0 | 0 | 0 | 0 |
| 2007-04 | 111,111 | 999,999 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Pharmasset Inc (VRUS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-13 | Rogers Michael D. (Chief Development Officer) | Sale | 16,672 | 18.48 | 305,777 |
| 2008-11-13 | Rogers Michael D. (Chief Development Officer) | Option Exercise | 16,672 | 13.88 | 231,407 |
| 2008-11-04 | Rogers Michael D. (Chief Development Officer) | Sale | 500 | 18.14 | 9,067 |
| 2008-11-04 | Rogers Michael D. (Chief Development Officer) | Option Exercise | 500 | 13.88 | 6,940 |
| 2008-11-03 | Rogers Michael D. (Chief Development Officer) | Sale | 1,578 | 18.00 | 28,404 |
| 2008-11-03 | Rogers Michael D. (Chief Development Officer) | Option Exercise | 1,578 | 13.88 | 21,902 |
| 2008-08-11 | Otto Michael (Chief Scientific Officer) | Sale | 5,835 | 21.49 | 125,412 |
| 2008-08-11 | Otto Michael (Chief Scientific Officer) | Option Exercise | 5,835 | 3.00 | 17,505 |
| 2008-06-23 | Evnin Luke (Other) | Sale | 28,937 | 19.97 | 577,871 |
| 2008-06-20 | Berrey M Michelle (Chief Medical Officer) | Option Exercise | 2,976 | 4.20 | 12,499 |
| 2008-06-19 | Evnin Luke (10% Owner) | Sale | 155,800 | 19.93 | 3,105,717 |
| 2008-06-19 | Gadicke Ansbert (Other) | Sale | 155,800 | 19.93 | 3,105,717 |
| 2008-06-17 | Gadicke Ansbert (10% Owner) | Sale | 101,900 | 20.18 | 2,056,596 |
| 2008-06-16 | Gadicke Ansbert (10% Owner) | Sale | 300,128 | 19.75 | 6,074,104 |
| 2008-06-13 | Gadicke Ansbert (10% Owner) | Sale | 1,321 | 19.00 | 25,099 |
| 2008-06-10 | Gadicke Ansbert (10% Owner) | Sale | 5,175 | 19.06 | 98,629 |
| 2008-06-05 | Gadicke Ansbert (10% Owner) | Sale | 10,083 | 19.15 | 193,049 |
| 2008-05-27 | Otto Michael (Chief Scientific Officer) | Sale | 81,264 | 17.67 | 1,435,889 |
| 2008-05-27 | Otto Michael (Chief Scientific Officer) | Option Exercise | 81,264 | 4.50 | 365,688 |
| 2008-05-19 | Berrey M Michelle (Chief Medical Officer) | Sale | 20,833 | 18.00 | 374,994 |
| 2008-05-19 | Berrey M Michelle (Chief Medical Officer) | Option Exercise | 20,833 | 4.20 | 87,498 |
| 2008-04-07 | Otto Michael (Exec.VP,Pharm.Research) | Sale | 100 | 20.00 | 2,000 |
| 2008-04-07 | Otto Michael (Exec.VP,Pharm.Research) | Option Exercise | 100 | 6.00 | 600 |
| 2008-04-04 | Otto Michael (Exec.VP,Pharm.Research) | Sale | 400 | 20.00 | 8,000 |
| 2008-04-04 | Otto Michael (Exec.VP,Pharm.Research) | Option Exercise | 400 | 6.00 | 2,400 |
| 2008-04-02 | Otto Michael (Exec.VP,Pharm.Research) | Sale | 37,900 | 20.02 | 758,833 |
| 2008-04-02 | Otto Michael (Exec.VP,Pharm.Research) | Option Exercise | 37,900 | 4.28 | 162,022 |
| 2008-04-02 | Henner Dennis (10% Owner) | Sale | 5,390 | 20.00 | 107,804 |
| 2008-04-02 | Simon Nicholas J Iii (10% Owner) | Sale | 5,117 | 20.00 | 102,340 |
| 2008-03-13 | Leutzinger Kurt (Executive VP & CFO) | Purchase | 1,000 | 16.32 | 16,320 |
| 2008-03-12 | Leutzinger Kurt (Executive VP & CFO) | Purchase | 4,000 | 15.60 | 62,400 |
| 2008-02-25 | Carney William J (Director) | Option Exercise | 26,666 | 3.00 | 79,998 |
| 2008-02-08 | Wheeler Kurt (10% Owner) | Sale | 6,874 | 21.36 | 146,828 |
| 2008-02-08 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 6,874 | 21.36 | 146,828 |
| 2008-02-08 | Gadicke Ansbert (10% Owner) | Sale | 27,925 | 21.36 | 596,478 |
| 2008-02-07 | Wheeler Kurt (10% Owner) | Sale | 17,450 | 23.02 | 401,699 |
| 2008-02-07 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 17,450 | 23.02 | 401,699 |
| 2008-02-07 | Gadicke Ansbert (10% Owner) | Sale | 36,664 | 23.02 | 844,005 |
| 2008-02-04 | Wheeler Kurt (10% Owner) | Sale | 12,993 | 23.86 | 310,012 |
| 2008-02-04 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 12,993 | 23.86 | 310,012 |
| 2008-02-04 | Gadicke Ansbert (10% Owner) | Sale | 27,300 | 23.86 | 651,378 |
| 2007-09-05 | Otto Michael (Exec.VP,Pharm.Research) | Option Exercise | 10,000 | 3.00 | 30,000 |
| 2007-08-09 | Leutzinger Kurt (Executive VP & CFO) | Option Exercise | 20,833 | 3.00 | 62,499 |
| 2007-05-02 | Wheeler Kurt (10% Owner) | Purchase | 277,777 | 9.00 | 2,499,993 |
| 2007-05-02 | Mpm Bioventures Iii Llc (10% Owner) | Purchase | 277,777 | 9.00 | 2,499,993 |
| 2007-05-02 | Burrill Life Sciences Capital Fund Lp (10% Owner) | Purchase | 222,222 | 9.00 | 1,999,998 |
| 2007-05-02 | Burrill Steven (Director) | Purchase | 222,222 | 9.00 | 1,999,998 |
| 2007-05-02 | Steinmetz Michael (10% Owner) | Purchase | 277,777 | 9.00 | 2,499,993 |
| 2007-05-02 | Gadicke Ansbert (Director) | Purchase | 277,777 | 9.00 | 2,499,993 |
| 2007-04-27 | Tvm V Life Science Ventures Management Gmbh & Co. (10% Owner) | Purchase | 111,111 | 9.00 | 999,999 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Pharmasset Inc (symbol VRUS,
CIK number 1301081) see
the Securities and Exchange Commission (SEC) website.
|
|
